The authors of a review article on the future of ustekinumab biosimilars for treating Crohn disease (CD) discussed key ...

Rebecca Hogan was stunned when she was diagnosed with Crohn’s disease in her early twenties. She didn’t know then about the ...

The two major types of IBD―Crohn’s disease and ulcerative colitis―present with overlapping but distinct symptoms. Crohn’s ...

This new technique, called GlycoCaging, allows powerful medicines to reach the inflamed part of the gut using much lower ...

Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...

In patients with IBD on maintenance IFX, use of 5-ASA and immunomodulators does not significantly reduce flares, infections, or adverse reactions.

Black patients face higher complications related to inflammatory bowel disease than White patients, according to a study presented at DDW 2025.

A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments.

The convenience advertisement from Houston Group feature real people from the CCA community who are living with IBD. Harrison ...

In time for May, which is Inflammatory Bowel Disease Awareness month, Crohn’s & Colitis Australia (CCA) have launched a ...

UBC researchers say they've made a breakthrough in the treatment of a disease that affects hundreds of thousands of Canadians. As Paul Johnson reports, they say the discovery could improve ...